keyword
MENU ▼
Read by QxMD icon Read
search

iRhythm

keyword
https://www.readbyqxmd.com/read/26883019/incidence-and-timing-of-potentially-high-risk-arrhythmias-detected-through-long-term-continuous-ambulatory-electrocardiographic-monitoring
#1
Matthew D Solomon, Jingrong Yang, Sue Hee Sung, Martha L Livingston, George Sarlas, Judith C Lenane, Alan S Go
BACKGROUND: Ambulatory electrocardiographic (ECG) monitoring is the standard to screen for high-risk arrhythmias. We evaluated the clinical utility of a novel, leadless electrode, single-patient-use ECG monitor that stores up to 14 days of a continuous recording to measure the burden and timing of potentially high-risk arrhythmias. METHODS: We examined data from 122,815 long term continuous ambulatory monitors (iRhythm ZIO® Service, San Francisco) prescribed from 2011 to 2013 and categorized potentially high-risk arrhythmias into two types: (1) ventricular arrhythmias including non-sustained and sustained ventricular tachycardia and (2) bradyarrhythmias including sinus pauses >3 s, atrial fibrillation pauses >5 s, and high-grade heart block (Mobitz Type II or third-degree heart block)...
2016: BMC Cardiovascular Disorders
https://www.readbyqxmd.com/read/25873476/feasibility-of-extended-ambulatory-electrocardiogram-monitoring-to-identify-silent-atrial-fibrillation-in-high-risk-patients-the-screening-study-for-undiagnosed-atrial-fibrillation-study-af
#2
Mintu P Turakhia, Aditya J Ullal, Donald D Hoang, Claire T Than, Jared D Miller, Karen J Friday, Marco V Perez, James V Freeman, Paul J Wang, Paul A Heidenreich
BACKGROUND: Identification of silent atrial fibrillation (AF) could prevent stroke and other sequelae. HYPOTHESIS: Screening for AF using continuous ambulatory electrocardiographic (ECG) monitoring can detect silent AF in asymptomatic in patients with known risk factors. METHODS: We performed a single-center prospective screening study using a wearable patch-based device that provides up to 2 weeks of continuous ambulatory ECG monitoring (iRhythm Technologies, Inc...
May 2015: Clinical Cardiology
https://www.readbyqxmd.com/read/25628595/diagnostic-yield-of-extended-cardiac-patch-monitoring-in-patients-with-stroke-or-tia
#3
Christie E Tung, Derek Su, Mintu P Turakhia, Maarten G Lansberg
BACKGROUND: It is important to evaluate patients with transient ischemic attack (TIA) or stroke for atrial fibrillation (AF) because the detection of AF changes the recommended anti-thrombotic regimen from treatment with an antiplatelet agent to oral anticoagulation. This study describes the diagnostic yield of a patch-based, single-use, and water-resistant 14-day continuous cardiac rhythm monitor (ZIO Patch) in patients with stroke or TIA. METHODS: We obtained data from the manufacturer and servicer of the ZIO Patch (iRhythm Technologies)...
2014: Frontiers in Neurology
https://www.readbyqxmd.com/read/24384108/comparison-of-24-hour-holter-monitoring-with-14-day-novel-adhesive-patch-electrocardiographic-monitoring
#4
COMPARATIVE STUDY
Paddy M Barrett, Ravi Komatireddy, Sharon Haaser, Sarah Topol, Judith Sheard, Jackie Encinas, Angela J Fought, Eric J Topol
BACKGROUND: Cardiac arrhythmias are remarkably common and routinely go undiagnosed because they are often transient and asymptomatic. Effective diagnosis and treatment can substantially reduce the morbidity and mortality associated with cardiac arrhythmias. The Zio Patch (iRhythm Technologies, Inc, San Francisco, Calif) is a novel, single-lead electrocardiographic (ECG), lightweight, Food and Drug Administration-cleared, continuously recording ambulatory adhesive patch monitor suitable for detecting cardiac arrhythmias in patients referred for ambulatory ECG monitoring...
January 2014: American Journal of Medicine
https://www.readbyqxmd.com/read/23668739/a-novel-patch-for-heart-rhythm-monitoring-is-the-holter-monitor-obsolete
#5
Steven L Higgins
A number of substantial improvements to the 60-year-old concept of the Holter monitor have recently been developed. One promising advance is the Zio(®) Patch (iRhythm Technologies, Inc., CA, USA), a small 2 × 5-inch patch, which can continuously record up to 14 days of a single ECG channel of cardiac rhythm without the need for removal during exercise, sleeping or bathing. Its ease-of-use, which enables optimal long-term monitoring, has been established in the ambulatory setting, although some insurance carriers have been reluctant to reimburse appropriately for this advance, an issue characteristic of other heart monitors, treated as 'loss-leaders...
May 2013: Future Cardiology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"